Yahoo Finance 
Global Asthma Clinical Trial Pipeline Report 2021: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Global Asthma Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
sthma Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Asthma market. It covers emerging therapies for Asthma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Asthma pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Asthma pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Asthma pipeline products by the company.
Short-term Launch Highlights:
Find out which Asthma pipeline products will be launched in the US and Ex-US till 2025.
SUMMARY:
Asthma phase 3 clinical trial pipeline products
Asthma phase 2 clinical trial pipeline products
Asthma phase 1 clinical trial pipeline products
Asthma preclinical research pipeline products
Asthma discovery stage pipeline products
Asthma pipeline products short-term launch highlights
Key Topics Covered:
1. Asthma Pipeline by Stages
2. Asthma Phase 3 Clinical Trial Insights
3. Asthma Phase 2 Clinical Trial Insights
4. Asthma Phase 1 Clinical Trial Insights
5. Asthma Preclinical Research Insights
6. Asthma Discovery Stage Insights
7. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/thv619
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
